8 patents
Utility
Method of Treating Psma-expressing Cancers
26 Oct 23
The present invention relates to combinations for use and methods of treating cancers that express prostate specific membrane antigen (PSMA).
Germo GERICKE, Jose-Maria GIMENEZ ANARU, Darshan DALAL
Filed: 30 Aug 21
Utility
Method of Treating Psma-expressing Cancers
12 Oct 23
The present invention relates to combinations for use and methods of treating cancers that express prostate specific membrane antigen (PSMA).
Germo GERICKE, Jose-Maria GIMENEZ ANARU, Darshan DALAL
Filed: 30 Aug 21
Utility
IL-17A/F Heterologous Polypeptides and Therapeutic Uses Thereof
30 Jun 22
The present invention is directed to a novel naturally occurring human cytokine that is comprised of a heterodimer of interleukin-17 and interleukin-17F designated herein as interleukin 17A/F (IL-17A/F).
David P Arnott, Mercedesz Balazs, Nico Ghilardi, Austin L. Gurney, Philip E. Hass, Sarah Hymowitz, James M. Lee, Wenjun Ouyang, Melissa A. Starovasnik, Yan Wu
Filed: 12 Jul 21
Utility
IL-17A/F Heterologous Polypeptides and Therapeutic Uses Thereof
9 Dec 20
The present invention is directed to a novel naturally occurring human cytokine that is comprised of a heterodimer of interleukin-17 and interleukin-17F designated herein as interleukin 17A/F (IL-17A/F).
David P. ARNOTT, Austin L. GURNEY, Philip E. HASS, James M. LEE, Yan WU
Filed: 1 Dec 19
Utility
IL-17A/F Heterologous Polypeptides and Therapeutic Uses Thereof
2 Dec 20
The present invention is directed to a novel naturally occurring human cytokine that is comprised of a heterodimer of interleukin-17 and interleukin-17F designated herein as interleukin 17A/F (IL-17A/F).
David P. ARNOTT, Mercedesz BALAZS, Nico GHILARDI, Austin L. GURNEY, Philip E. HASS, Sarah HYMOWITZ, James M. LEE, Wenjun OUYANG, Melissa A. STAROVASNIK, Yan WU
Filed: 5 Feb 20
Utility
IL-17A/F Heterologous Polypeptides and Therapeutic Uses Thereof
2 Dec 20
The present invention is directed to a novel naturally occurring human cytokine that is comprised of a heterodimer of interleukin-17 and interleukin-17F designated herein as interleukin 17A/F (IL-17A/F).
David P. ARNOTT, Austin L. GURNEY, Philip E. HASS, James M. LEE, Yan WU
Filed: 6 Jan 20
Utility
Computer-implemented methods of determining protein viscosity
31 Aug 20
Provided herein are high-throughput methods for identifying a candidate antibody based on viscosity of the candiate antibody.
Bernhardt Levy Trout, Bernhard Helk, Neeraj Jagdish Agrawal
Filed: 15 May 14
Utility
Stable Multiple Antigen-binding Antibody
12 Feb 20
The invention provides antibodies that bind to multiple antigens, said antibodies having at least two antibody light chain variable domains and two antibody heavy chain variable domains, wherein each light chain variable domain is linked to a heavy chain variable domain to form a VH/VL construct, and wherein at least one of the VH domains comprises a particular amino acid at AHo position 12, 103 and/or 144, and at least one of the VL domains comprises a particular amino acid at AHo position 47 and/or 50.
Astrid C. Riegler, Leonardo Jose Borras, Roberto Sommavilla
Filed: 26 Feb 19
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first